FDA.reportPublic FDA data

letrozole 2.5 MG (28) / ribociclib 200 MG (21) Pack

RxCUI
1923053
RxNorm name
letrozole 2.5 MG (28) / ribociclib 200 MG (21) Pack
Display name
letrozole 2.5 MG (28) / ribociclib 200 MG (21) Pack
Full name
letrozole 2.5 MG (28) / ribociclib 200 MG (21) Pack
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:14

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
KISQALI FEMARA CO-PACKLETROZOLE AND RIBOCICLIBNovartis Pharmaceuticals Corporationaa5e4446-19cd-4235-a382-5b48bf6c3b2f2026-07-01Warnings, Adverse reactionsExact identifier
rxcui: 1923053

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
aa5e4446-19cd-4235-a382-5b48bf6c3b2fletrozole 2.5 MG (28) / ribociclib 200 MG (21) PackSY25These highlights do not include all the information needed to use KISQALI FEMARA CO-PACK safely and effectively. See full prescribing information for KISQALI FEMARA CO-PACK. KISQALI ® FEMARA ® CO-PACK (ribociclib tablets; letrozole tablets), co-packaged for oral use Initial U.S. Approval: 201720250916
aa5e4446-19cd-4235-a382-5b48bf6c3b2f{28 (letrozole 2.5 MG Oral Tablet) / 21 (ribociclib 200 MG Oral Tablet) } PackGPCK25These highlights do not include all the information needed to use KISQALI FEMARA CO-PACK safely and effectively. See full prescribing information for KISQALI FEMARA CO-PACK. KISQALI ® FEMARA ® CO-PACK (ribociclib tablets; letrozole tablets), co-packaged for oral use Initial U.S. Approval: 201720250916
aa5e4446-19cd-4235-a382-5b48bf6c3b2fribociclib 200 MG / letrozole 2.5 MG Daily Dose CartonPSN25These highlights do not include all the information needed to use KISQALI FEMARA CO-PACK safely and effectively. See full prescribing information for KISQALI FEMARA CO-PACK. KISQALI ® FEMARA ® CO-PACK (ribociclib tablets; letrozole tablets), co-packaged for oral use Initial U.S. Approval: 201720250916